Fig. 2 | Scientific Reports

Fig. 2

From: Clonal hematopoiesis impacts frailty in newly diagnosed multiple myeloma patients: a retrospective multicenter analysis

Fig. 2The alternative text for this image may have been generated using AI.

CHIP is associated with greater biological aggressiveness of the disease. (A) Histogram plot showing BMPCs ≥ 60% in CHIP (red) carriers compared with those without abnormalities (blue). Data are mean ± SD; ns = not significant (Kolmogorov–Smirnov test). (B) Regression analysis correlating VAF in BMSCs (CD138NEG) and PBMCs across the entire cohort. R = 0.97; p < 0.0001(unpaired t-test). (C) Violin plot displaying β2-microglobulin, 24 h protein urine, creatinine, serum FLC k, eGFR and hemoglobin levels between samples with CHIP (red) and those without (blue). Statistically significant differences are marked by asterisk. Data are mean ± SD; *p = 0.05, **p = 0.03, ***p = 0.02 (Kolmogorov–Smirnov test). (D) MOSAIC plot related to Person’s chi-squared test, showing the relationship between CHIP and ISS and R-ISS stages (I-III).

Back to article page